enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Biocon - Wikipedia

    en.wikipedia.org/wiki/Biocon

    Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. [ 4 ] The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, [ 5 ] including the United States and Europe. [ 4 ]

  3. India's Biocon in talks with Mylan to merge biosimilar ... - AOL

    www.aol.com/news/indias-biocon-talks-mylan-merge...

    Spokespersons for Biocon and Viatris Inc, the company which was formed after combining Mylan with Pfizer Inc's off-patent branded drugs business, said that the companies do not comment on market ...

  4. Kiran Mazumdar-Shaw - Wikipedia

    en.wikipedia.org/wiki/Kiran_Mazumdar-Shaw

    Kiran Mazumdar-Shaw (born 23 March 1953) is an Indian billionaire entrepreneur. [3] She is the executive chairperson and founder of Biocon Limited and Biocon Biologics Limited, [4] a biotechnology company based in Bangalore, India [5] and the former chairperson of Indian Institute of Management, Bangalore. [6]

  5. Biotechnology in India - Wikipedia

    en.wikipedia.org/wiki/Biotechnology_in_India

    Biotechnology in India is a sunrise sector within the Indian economy. [1] Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion. [2]

  6. India's Biocon developing its own version of Wegovy, clinical ...

    www.aol.com/news/indias-biocon-developing-own...

    Indian drugmaker Biocon, looking to grab a piece of the exploding weight-loss drug market as early as possible, is developing its own version of Novo Nordisk's wildly popular Wegovy and is ...

  7. India's Biocon in talks with Mylan to merge biosimilar ... - AOL

    www.aol.com/news/indias-biocon-talks-mylan-merge...

    Indian drugmaker Biocon Ltd is in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, financial news website Moneycontrol reported https://bit.ly/3dxe54j on Thursday ...

  8. Qualified institutional placement - Wikipedia

    en.wikipedia.org/wiki/Qualified_institutional...

    Qualified institutional placement (QIP) is a capital-raising tool, primarily used in India and other parts of southern Asia, whereby a listed company can issue equity shares, fully and partly convertible debentures, or any securities other than warrants which are convertible to equity shares to a qualified institutional buyer (QIB).

  9. India's Biocon Mulls Merger Of Biosimilar Business With Mylan ...

    www.aol.com/news/indias-biocon-mulls-merger...

    India-based Biocon Ltd is reportedly in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, financial news website Moneycontrol reported, citing sources with direct ...